Lithium treatment reduces suicide risk in recurrent major depressive disorder

Journal of Clinical Psychiatry

Volumn 68, Issue 3, 2007, Pages 380-383

  Guzzetta, Francesca ^a,b,c   Tondo, Leonardo ^a,b,d,e   Centorrino, Franca ^a,b   Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e Lucio Bini Mood Disorder Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; LITHIUM CARBONATE;

ARTICLE; CLINICAL TRIAL; HUMAN; MAJOR DEPRESSION; META ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW;

EID: 33947731833     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0304     Document Type: Article

References (38)

1. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997;170:205-228
2. American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors. Am J Psychiatry 2003;160(suppl 11):1-60
3. Tondo L, Isacsson G, Baldessarini R. Suicidal behavior in bipolar disorder: risk and prevention. CNS Drugs 2003;17:491-511
4. Schou M. Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disord 1999;1:5-10
5. Davis JM. Lithium maintenance of unipolar depression. In: Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry. Abingdon, UK: Informa Healthcare; 2006:99-108
6. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001;104:163-172
7. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003;290:1467-1473
8. Müller-Oerlinghausen B, Berghöfer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry 2003;48:433-439
9. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005;162:1805-1819
10. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006;8(5 pt 2):625-639
11. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790-792
12. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, Lazo JS, Parker KL, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005:429-459
13. Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychosis and mania. In: Brunton LL, Lazo JS, Parker KL, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005:461-500
14. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005;330:385-389
15. Angst J, Angst F, Gerber-Werder R, et al. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005;9:279-300
16. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339
17. Tondo L, Baldessarini RJ, Hennen J, et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405-414
18. Bech P, Vendsborg PB, Rafaelsen OJ. Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiatr Scand 1976;53:70-81
19. Lepkifker E, Horesh N, Floru S. Long-term lithium prophylaxis in recurrent unipolar depression: a controversial indication? Acta Psychiatr Belg 1985;85:434-443
20. Müller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;25:261-269
21. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 1996;40:179-190
22. Bocchetta A, Ardau R, Burrai C, et al. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J Clin Psychopharmacol 1998;18:384-389
23. Coppen A, Farmer R. Suicide mortality in patients on lithium maintenance therapy. J Affect Disord 1998;50:261-267
24. Bauer M, Bschor T, Kunz D, et al. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 2000;157:1429-1435
25. Baldessarini RJ, Tondo L, Faedda GL, et al. Latency, discontinuation, and re-use of lithium treatment. In: Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry. Abingdon, UK: Informa Healthcare; 2006:465-481
26. Baethge C, Gruschka P, Smolka MN, et al. Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder. J Psychiatry Neurosci 2003;28:355-361
27. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 2005;85:245-258
28. Cassano GB, Rucci P, Frank E, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry 2004;161:1264-1269
29. Müller-Oerlinghausen B, Ahrens B, Felber W. The suicide-preventive and mortality-reduced effect of lithium. In: Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry. Abingdon, UK: Informa Healthcare; 2006:179-192
30. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry 2006;63:246-248
31. Filteau MJ, Lapierre YD, Bakish D, et al. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatry Neurosci 1993;18:114-119
32. Pedersen AG. Escitalopram and suicidality in adult depression and anxiety. Int Clin Psychopharmacol 2005;20:139-143
33. Bailey B, McGuigan M. Lithium poisoning from a poison control center perspective. Ther Drug Monit 2000;22:650-655
34. Waddington D, McKenzie IP. Overdose rates in lithium-treated versus antidepressant-treated outpatients. Acta Psychiatr Scand 1994;90:50-52
35. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry 2001;35:833-840
36. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005;23:589-666
37. Eyer F, Pfab R, Felgenhauer N, et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharmacol 2006;26:325-330
38. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91